Mycenax Biotech Inc. (4726.TWO)
TWD 33.75
(-10.0%)
TWD 33.75
(-10.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -339.48 Million TWD | -164.04% |
| 2022 | -160.33 Million TWD | -271.7% |
| 2021 | 82.83 Million TWD | -57.22% |
| 2020 | 176.89 Million TWD | 241.58% |
| 2019 | -104.76 Million TWD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -15.41 Million TWD | 71.03% |
| 2024 Q1 | -50.4 Million TWD | 30.76% |
| 2023 Q4 | -66.02 Million TWD | -13.04% |
| 2023 FY | - TWD | -164.04% |
| 2023 Q3 | -58.4 Million TWD | -1.81% |
| 2023 Q2 | -57.37 Million TWD | 64.43% |
| 2023 Q1 | -161.28 Million TWD | -54.96% |
| 2022 FY | - TWD | -271.7% |
| 2022 Q4 | -104.08 Million TWD | 0.0% |
| 2021 FY | - TWD | -57.22% |
| 2020 FY | - TWD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | -46.24 Million TWD | -634.113% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 393.6 Million TWD | 186.25% |
| Level Biotechnology Inc. | 98.7 Million TWD | 443.94% |
| Sagittarius Life Science Corp | -44.73 Million TWD | -658.808% |
| NeoCore Technology Co., Ltd. | -72.11 Million TWD | -370.752% |
| TaiMed Biologics Inc. | -25.23 Million TWD | -1245.393% |
| GlycoNex Incorporation | -126.82 Million TWD | -167.674% |
| VBI | -6.97 Million TWD | -4769.234% |
| GeneReach Biotechnology Corp. | -143.69 Million TWD | -136.252% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 21.81 Million TWD | 1656.547% |
| SynCore Biotechnology Co.,Ltd | -17.72 Million TWD | -1815.17% |
| Genomics BioSci & Tech. Co.,Ltd. | -103.61 Million TWD | -227.639% |
| Visgeneer Inc. | 973 Thousand TWD | 34990.339% |
| Sunmax Biotechnology Co., Ltd. | 936.46 Million TWD | 136.251% |
| G&E Herbal Biotechnology Co., Ltd. | 99.83 Million TWD | 440.037% |
| Neith Corporation | -33.61 Million TWD | -910.065% |
| Medigen Vaccine Biologics Corporation | -991.09 Million TWD | 65.747% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -1.73 Million TWD | -19444.214% |
| Enimmune corporation | -228.96 Million TWD | -48.27% |
| TaiRx, Inc. | -208.64 Million TWD | -62.708% |
| CHO Pharma, Inc. | -277.73 Million TWD | -22.234% |
| EirGenix Inc. | -664.4 Million TWD | 48.904% |
| BioLASCO Taiwan Co., Ltd. | 73.9 Million TWD | 559.357% |
| Sunny Pharmtech Inc. | 69.14 Million TWD | 590.987% |
| Lin BioScience, Inc. | -1.07 Billion TWD | 68.314% |
| BioGend Therapeutics Co., Ltd. | -113.1 Million TWD | -200.146% |
| Feng Chi Biotech Corp. | 34.83 Million TWD | 1074.462% |
| Bio Preventive Medicine Corp. | -62.34 Million TWD | -444.558% |
| Lukas Biomedical Inc. | -26.3 Million TWD | -1190.81% |
| RBC Bioscience Corporation | 36.54 Million TWD | 1028.894% |
| BiOptic Inc. | 65.03 Million TWD | 621.976% |
| BRIM Biotechnology, Inc. | -682.46 Million TWD | 50.256% |
| Shine-On BioMedical Co.,Ltd. | -33 Million TWD | -928.549% |
| Great Novel Therapeutics Biotech & Medicals | -54.91 Million TWD | -518.197% |
| Syngen Biotech Co.,Ltd. | 433.55 Million TWD | 178.302% |
| Advagene Biopharma Co., Ltd. | -80.07 Million TWD | -323.972% |
| NaviFUS Corp. | -55.79 Million TWD | -508.447% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -16.59 Million TWD | -1945.325% |
| Sinew Pharma Inc. | -163.63 Million TWD | -107.469% |
| Andros Pharmaceuticals Co.,Ltd | -61.5 Million TWD | -452.005% |
| Greenyn Biotechnology Co., Ltd | 192.4 Million TWD | 276.445% |
| Lumosa Therapeutics Co., Ltd. | -226.67 Million TWD | -49.764% |
| AP Biosciences Inc | -325.51 Million TWD | -4.292% |
| Medigen Biotechnology Corp. | -1.04 Billion TWD | 67.502% |
| 3D Global Biotech Inc. | -35.84 Million TWD | -847.06% |
| Pharmosa Biopharm Inc. | 29.13 Million TWD | 1265.407% |
| Intech Biopharm Corporation | -219.58 Million TWD | -54.602% |
| Oneness Biotech Co., Ltd. | -674.22 Million TWD | 49.649% |
| Eusol Biotech Co.,Ltd. | -44.95 Million TWD | -655.229% |
| TWi Biotechnology, Inc. | -160.85 Million TWD | -111.046% |
| Ever Supreme Bio Technology Co., Ltd | 655.52 Million TWD | 151.788% |
| TCI GENE Inc. | 25.98 Million TWD | 1406.659% |
| MegaPro Biomedical Co., Ltd | -110.63 Million TWD | -206.841% |
| Senhwa Biosciences, Inc. | -283.78 Million TWD | -19.627% |
| Taiwan Bio Therapeutics Co., Ltd | -145.97 Million TWD | -132.57% |
| NatureWise Biotech & Medicals Corporation | 13.85 Million TWD | 2551.141% |
| PharmaEngine, Inc. | 347.3 Million TWD | 197.748% |
| Savior Lifetec Corporation | 219.6 Million TWD | 254.588% |
| TaiGen Biopharmaceuticals Holdings Limited | 172.23 Million TWD | 297.11% |
| OBI Pharma, Inc. | -855.08 Million TWD | 60.298% |
| Meribank Biotech Co., Ltd | -92.56 Million TWD | -266.759% |
| Acepodia, Inc. | -764.51 Million TWD | 55.595% |
| Caliway Biopharmaceuticals Co., Ltd. | -460.09 Million TWD | 26.214% |